Orphazyme A/S
Latest round
- Series B
Last raised
- Mar 2017
Total raised
- $62M
Investors
- 7
About Orphazyme A/S
Founded in 2009, Orphazyme A/S operates in the biopharmaceutical sector, concentrating on treatments for rare diseases. The firm has undergone strategic changes, including a significant pivot in its business model and focus on enzyme replacement therapies.Orphazyme A/S focuses on developing biopharmaceuticals that target rare diseases, particularly enzyme replacement therapies. The company is engaged in creating therapies that address unmet medical needs in conditions characterized by protein aggregation.Orphazyme A/S aims to expand its product offerings and enter new markets for its enzyme replacement therapies. As it continues to innovate, Orphazyme is positioned to explore geographic expansion into new regions to increase its market presence and drive growth.
Who invested in Orphazyme A/S
7 investors across 4 rounds
See all investors in Orphazyme A/S
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Orphazyme A/S
Who invested in Orphazyme A/S?
Orphazyme A/S has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Orphazyme A/S raised?
Orphazyme A/S has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Orphazyme A/S last raise money?
Orphazyme A/S's most recent round on record is a Series B, in Mar 2017.
What does Orphazyme A/S do?
Founded in 2009, Orphazyme A/S operates in the biopharmaceutical sector, concentrating on treatments for rare diseases.
Where is Orphazyme A/S headquartered?
Orphazyme A/S is headquartered in Copenhagen, Denmark.
Which VCs invest in companies like Orphazyme A/S?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Orphazyme A/S's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Orphazyme A/S? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.